Literature DB >> 9876962

Frontotemporal behavioral scale.

F Lebert1, F Pasquier, L Souliez, H Petit.   

Abstract

At autopsy, frontotemporal dementia (FTD) account for up to 20% of degenerative dementia cases, although FTDs are underrecognized in memory clinics. FTDs are confused with Alzheimer disease (AD) or vascular dementia (VaD). These misdiagnosis may affect the results of AD pharmacological trials. The first manifestations of FTD are behavioral abnormalities. The aim of this study was to assess a behavioral scale of frontal lobe dysfunction and to determine a behavioral cutoff to diagnose early FTD and distinguish it from AD and VaD. The score of the behavioral frontotemporal lobe dysfunction assessment scale was higher in FTD than in other dementias (p < 0.0001). With a cutoff of 3 points on the scale, FTD patients were diagnosed with a specificity of 95% and sensitivity of 91%. Noncognitive symptoms known to be institutionalization factors could contribute to differences between etiologies of mild dementia.

Entities:  

Mesh:

Year:  1998        PMID: 9876962     DOI: 10.1097/00002093-199812000-00014

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  14 in total

1.  Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction.

Authors:  Roberta Perri; Giacomo Koch; Giovanni A Carlesimo; Laura Serra; Lucia Fadda; Patrizio Pasqualetti; Carla Pettenati; Carlo Caltagirone
Journal:  J Neurol       Date:  2005-05-23       Impact factor: 4.849

2.  Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia.

Authors:  Gabriel C Léger; Sarah J Banks
Journal:  Dement Geriatr Cogn Disord       Date:  2013-10-10       Impact factor: 2.959

3.  The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease.

Authors:  Alice Jaillard; Matthieu Vanhoutte; Aurélien Maureille; Susanna Schraen; Emilie Skrobala; Xavier Delbeuck; Adeline Rollin-Sillaire; Florence Pasquier; Stéphanie Bombois; Franck Semah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-28       Impact factor: 9.236

4.  Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?

Authors:  S Bozeat; C A Gregory; M A Ralph; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

5.  [Frontotemporal dementia. Results from "Frontotemporal Demential and Pick's Disease Conference"].

Authors:  J Diehl; I R Mackenzie; H Förstl; A Kurz
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

6.  Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias.

Authors:  Katherine P Rankin; Wendy Santos-Modesitt; Joel H Kramer; Danijela Pavlic; Victoria Beckman; Bruce L Miller
Journal:  J Clin Psychiatry       Date:  2008-01       Impact factor: 4.384

7.  Dietary Vitamin K Intake Is Associated with Cognition and Behaviour among Geriatric Patients: The CLIP Study.

Authors:  Justine Chouet; Guylaine Ferland; Catherine Féart; Yves Rolland; Nancy Presse; Kariane Boucher; Pascale Barberger-Gateau; Olivier Beauchet; Cedric Annweiler
Journal:  Nutrients       Date:  2015-08-12       Impact factor: 5.717

8.  Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders.

Authors:  Renaud David; Emmanuel Mulin; Patrick Mallea; Philippe H Robert
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-26

9.  The clinical differentiation of fronto-temporal dementia from psychiatric disease.

Authors:  Peter K Panegyres; Angela Graves; Kate A R Frencham
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

10.  Identification of biomarkers that predict response to subthalamic nucleus deep brain stimulation in resistant obsessive-compulsive disorder: protocol for an open-label follow-up study.

Authors:  Shyam Sundar Arumugham; Dwarakanath Srinivas; Janardhanan C Narayanaswamy; T S Jaisoorya; Himani Kashyap; Philippe Domenech; Stéphane Palfi; Luc Mallet; Ganesan Venkatasubramanian; Yc Janardhan Reddy
Journal:  BMJ Open       Date:  2021-06-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.